Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Ceramide glucosyltransferase homolog | 0.2002 | 1 | 1 |
Echinococcus multilocularis | ceramide glucosyltransferase | 0.2002 | 1 | 1 |
Schistosoma mansoni | ceramide glucosyltransferase | 0.2002 | 1 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.154 | 0.7474 | 0.7295 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.154 | 0.7474 | 0.7295 |
Echinococcus multilocularis | bile acid beta glucosidase | 0.1529 | 0.741 | 0.7227 |
Echinococcus granulosus | non lysosomal glucosylceramidase | 0.1529 | 0.741 | 0.7227 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0296 | 0.0662 | 0.5 |
Onchocerca volvulus | 0.0925 | 0.4108 | 0.1695 | |
Echinococcus multilocularis | non lysosomal glucosylceramidase | 0.1529 | 0.741 | 0.7227 |
Loa Loa (eye worm) | ceramide glucosyltransferase | 0.2002 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0296 | 0.0662 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0706 | 0.2906 | 0.5258 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0706 | 0.2906 | 0.5258 |
Schistosoma mansoni | alpha-glucosidase | 0.1377 | 0.658 | 0.658 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0296 | 0.0662 | 0.5 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.154 | 0.7474 | 0.7295 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0296 | 0.0662 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.1075 | 0.4929 | 1 |
Schistosoma mansoni | ceramide glucosyltransferase | 0.2002 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0706 | 0.2906 | 0.5258 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0744 | 0.3113 | 0.5745 |
Trypanosoma brucei | glucosidase, putative | 0.0296 | 0.0662 | 0.5 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.1075 | 0.4929 | 0.457 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0296 | 0.0662 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.1075 | 0.4929 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.1075 | 0.4929 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.1075 | 0.4929 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0706 | 0.2906 | 0.5258 |
Echinococcus granulosus | ceramide glucosyltransferase | 0.2002 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0706 | 0.2906 | 0.5258 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0296 | 0.0662 | 0.5 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.1075 | 0.4929 | 0.457 |
Giardia lamblia | Ceramide glucosyltransferase | 0.0908 | 0.4011 | 0.5 |
Schistosoma mansoni | alpha glucosidase | 0.0296 | 0.0662 | 0.0662 |
Loa Loa (eye worm) | hypothetical protein | 0.1032 | 0.4691 | 0.4315 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.154 | 0.7474 | 0.7295 |
Schistosoma mansoni | alpha-glucosidase | 0.1377 | 0.658 | 0.658 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.154 | 0.7474 | 0.7295 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.1075 | 0.4929 | 1 |
Schistosoma mansoni | bile acid beta-glucosidase-related | 0.1529 | 0.741 | 0.741 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0744 | 0.3113 | 0.5745 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.1075 | 0.4929 | 1 |
Schistosoma mansoni | bile acid beta-glucosidase-related | 0.1529 | 0.741 | 0.741 |
Echinococcus granulosus | bile acid beta glucosidase | 0.1529 | 0.741 | 0.7227 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0706 | 0.2906 | 0.5258 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0706 | 0.2906 | 0.5258 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | > 10 mM | Tested for binding activity against Selectin E of the compound; inactive | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.